Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Fuligni

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Italian Journal of Dermatology and Venereology|December 6, 2019
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis?Alessandro Pileri, Alba Guglielmo, Fabio Fuligni, et al.
Cancer Genetics|September 29, 2020
First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemiaSneha Tandon, Mary Shago, Scott Davidson, et al.
Italian Journal of Dermatology and Venereology|April 4, 2022
PD-1 and PD-L1 expression in mycosis fungoides and Sézary SyndromeAlessandro Pileri, Valentina Tabanelli, Fabio Fuligni, et al.
Histopathology|April 29, 2014
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoidesAlessandro Pileri, Claudio Agostinelli, Simona Righi, et al.
Cancers|March 29, 2023
Use of Next Generation Sequencing to Define the Origin of Primary MyelofibrosisGiuseppe Visani, Maryam Etebari, Fabio Fuligni, et al.
Oncotarget|March 20, 2015
Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growthMarco Pizzi, Francesco Piazza, Claudio Agostinelli, et al.
Human Pathology|October 25, 2016
Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiologyMarco Pizzi, Fabio Fuligni, Luisa Santoro, et al.
Journal of Genomics|July 18, 2014
Enly: Improving Draft Genomes through Reads RecyclingMarco Fondi, Valerio Orlandini, Giorgio Corti, et al.
Leukemia Research|October 9, 2017
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II studyGiuseppe Visani, Felicetto Ferrara, Francesco Di Raimondo, et al.
Cancer Research|April 11, 2015
SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute LeukemiasCaterina Vitali, Claudia Bassani, Claudia Chiodoni, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Italian Journal of Dermatology and Venereology|December 6, 2019
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis?Alessandro Pileri, Alba Guglielmo, Fabio Fuligni, et al.
Cancer Genetics|September 29, 2020
First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemiaSneha Tandon, Mary Shago, Scott Davidson, et al.
Italian Journal of Dermatology and Venereology|April 4, 2022
PD-1 and PD-L1 expression in mycosis fungoides and Sézary SyndromeAlessandro Pileri, Valentina Tabanelli, Fabio Fuligni, et al.
Histopathology|April 29, 2014
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoidesAlessandro Pileri, Claudio Agostinelli, Simona Righi, et al.
Cancers|March 29, 2023
Use of Next Generation Sequencing to Define the Origin of Primary MyelofibrosisGiuseppe Visani, Maryam Etebari, Fabio Fuligni, et al.
Oncotarget|March 20, 2015
Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growthMarco Pizzi, Francesco Piazza, Claudio Agostinelli, et al.
Human Pathology|October 25, 2016
Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiologyMarco Pizzi, Fabio Fuligni, Luisa Santoro, et al.
Journal of Genomics|July 18, 2014
Enly: Improving Draft Genomes through Reads RecyclingMarco Fondi, Valerio Orlandini, Giorgio Corti, et al.
Leukemia Research|October 9, 2017
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II studyGiuseppe Visani, Felicetto Ferrara, Francesco Di Raimondo, et al.
Cancer Research|April 11, 2015
SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute LeukemiasCaterina Vitali, Claudia Bassani, Claudia Chiodoni, et al.
Pageof 5